In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugo is a targeted therapy drug for the treatment of low-grade serous ovaria···【more】
Release date:2024-08-23Recommended:265
Koselugois an anti-cancer drug targeting MEK protein, which can successfully blo···【more】
Release date:2024-08-23Recommended:230
Koselugo is an MEK protein-targeted anticancer agent that can effectively cut th···【more】
Release date:2024-08-23Recommended:243
Koselugo is an anti-cancer drug targeting MEK protein, which inhibits tumor cell···【more】
Release date:2024-08-23Recommended:323
By targeting and inhibiting the activity of MEK protein, Koselugo effectively cu···【more】
Release date:2024-08-23Recommended:273
Koselugoinhibits tumor cell proliferation by inhibiting MEK protein activity, bl···【more】
Release date:2024-08-23Recommended:232
Koselugo is a targeted therapy drug primarily used to treat a specific subtype o···【more】
Release date:2024-08-23Recommended:266
Alpelisib is a drug for the treatment of HR/HER2- breast cancer, especially for ···【more】
Release date:2024-08-22Recommended:236
Alpelisib for the treatment of PIK3CA-mutated HR/HER2- advanced breast cancer in···【more】
Release date:2024-08-22Recommended:228
Alpelisib, approved in combination with fulvestrant in 2019 for the treatment of···【more】
Release date:2024-08-22Recommended:249
Anamorelin is a ghrelin receptor agonist used to treat cancer cachexia and signi···【more】
Release date:2024-08-22Recommended:198
Anamorelin is currently the only effective therapeutic drug that promotes appeti···【more】
Release date:2024-08-22Recommended:195